Trial Profile
An International, Multicenter, Randomized, Double-blind, Double-dummy, Two-way, Parallel Group, Controlled Study to Compare the Efficacy and Safety of Intravenous and Oral Nemonoxacin Versus Tavanic in Adult Patients With Community-acquired Pneumonia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Feb 2023
Price :
$35
*
At a glance
- Drugs Nemonoxacin (Primary) ; Nemonoxacin (Primary) ; Levofloxacin; Levofloxacin
- Indications Community-acquired pneumonia
- Focus Registrational; Therapeutic Use
- Sponsors R-Pharm
- 13 Jun 2018 New trial record